Q3 2024 · 13F-HR
SECTOR GAMMA ASholdings as filed
Filed 2024-11-13 · accession 0000945621-24-000926
$329.6M
Reported value
29
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 110122108 | BMY | BRISTOL-MYERS SQUIBB CO | $31.1M | 9.45% | 602,000 | Common | SOLE |
| G5960L103 | MDT | MEDTRONIC PLC | $30.2M | 9.15% | 334,890 | Common | SOLE |
| 375558103 | GILD | GILEAD SCIENCES INC | $24.2M | 7.36% | 289,163 | Common | SOLE |
| 717081103 | PFE | PFIZER INC | $23.7M | 7.20% | 820,000 | Common | SOLE |
| 126650100 | CVS | CVS HEALTH CORP | $19.0M | 5.76% | 302,000 | Common | SOLE |
| 075887109 | BDX | BECTON DICKINSON & CO | $18.6M | 5.65% | 77,280 | Common | SOLE |
| 45337C102 | INCY | INCYTE CORP | $17.1M | 5.19% | 259,000 | Common | SOLE |
| 071813109 | BAX | BAXTER INTL INC | $14.6M | 4.44% | 385,000 | Common | SOLE |
| 036752103 | ELV | ELEVANCE HEALTH INC | $13.7M | 4.15% | 26,279 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $13.4M | 4.06% | 190,348 | Common | SOLE |
| 14149Y108 | CAH | CARDINAL HEALTH INC | $12.9M | 3.93% | 117,098 | Common | SOLE |
| 98956P102 | ZBH | ZIMMER BIOMET HOLDINGS INC | $11.4M | 3.47% | 106,000 | Common | SOLE |
| 116794108 | BRKR | BRUKER CORP | $11.0M | 3.33% | 158,970 | Common | SOLE |
| N72482149 | — | QIAGEN NV | $10.2M | 3.09% | 223,124 | Common | SOLE |
| 36266G107 | GEHC | GE HEALTHCARE TECHNOLOGIES I | $10.0M | 3.04% | 106,700 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $8.4M | 2.56% | 210,842 | Common | SOLE |
| 15135B101 | CNC | CENTENE CORP DEL | $7.2M | 2.17% | 95,000 | Common | SOLE |
| 28176E108 | EW | EDWARDS LIFESCIENCES CORP | $7.0M | 2.13% | 106,153 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $6.8M | 2.07% | 35,166 | Common | SOLE |
| 090572207 | BIO | BIO RAD LABS INC | $5.6M | 1.71% | 16,829 | Common | SOLE |
| 031162100 | AMGN | AMGEN INC | $5.2M | 1.56% | 16,000 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $4.8M | 1.44% | 40,000 | Common | SOLE |
| 88033G407 | THC | TENET HEALTHCARE CORP | $4.4M | 1.33% | 26,361 | Common | SOLE |
| 913903100 | UHS | UNIVERSAL HLTH SVCS INC | $4.0M | 1.22% | 17,627 | Common | SOLE |
| 444859102 | HUM | HUMANA INC | $3.8M | 1.15% | 12,000 | Common | SOLE |
| 516544103 | LNTH | LANTHEUS HLDGS INC | $3.5M | 1.06% | 31,712 | Common | SOLE |
| 00847X104 | AGIO | AGIOS PHARMACEUTICALS INC | $3.0M | 0.92% | 67,908 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $2.8M | 0.85% | 100,000 | Common | SOLE |
| 52490G102 | LEGN | LEGEND BIOTECH CORP | $1.9M | 0.57% | 38,762 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.